Tesaro is reportedly on the auction block, but who can afford it?
Tesaro is up on the auction block, The Wall Street Journal is reporting. But don’t be surprised if no one comes up and gobbles this one up fast. Analysts believe Tesaro has a blockbuster on its hands with its newly approved PARP inhibitor Zejula and it won’t go cheap.
The Journal says that Waltham, MA-based Tesaro has sent out a request for bids over the last few weeks, but interest seems tepid.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.